Tag Archive for: Mylan Pharmaceuticals Inc.

Drugmaker Viatris Inc. is considering a potential sale of its consumer health assets in Europe in a deal that could be valued at over 3 billion euros ($2.9 billion), Bloomberg News reported on Tuesday, citing people familiar with the matter.

The U.S. Supreme Court on Monday declined to hear Biogen Inc’s (BIIB.O) bid to win reinstatement of a patent on the company’s blockbuster multiple sclerosis drug Tecfidera in a dispute with Viatris Inc. subsidiary (VTRS.O) Mylan Pharmaceuticals Inc.